Ordering Patern and Performance of Biochemical Tests for Diagnosing Pheochromocytoma Between 2000 and 2008

Endocrine Practice

Volumn 15, Issue 4, 2009, Pages 313-321

  Yu, Run ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; METADRENALIN; VANILMANDELIC ACID;

ADULT; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CHEMICAL ANALYSIS; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PHEOCHROMOCYTOMA; SENSITIVITY AND SPECIFICITY; UNITED STATES; URINALYSIS; URINE LEVEL; ADOLESCENT; AGED; BLOOD; MIDDLE AGED; PREDICTION AND FORECASTING; URINE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CATECHOLAMINES; FEMALE; HUMANS; MALE; METANEPHRINE; MIDDLE AGED; PHEOCHROMOCYTOMA; PREDICTIVE VALUE OF TESTS; VANILMANDELIC ACID; YOUNG ADULT;

EID: 67649221901     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP09032OR     Document Type: Article

References (23)

1. Bravo EL, Tagle R. Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev. 2003;24:539-553.
2. Manger WM. An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges. Ann N Y Acad Sci. 2006;1073:1-20.
3. Onusko E. Diagnosing secondary hypertension. Am Fam Physician. 2003;67:67-74.
4. Chiong JR, Aronow WS, Khan IA, et al. Secondary hypertension: current diagnosis and treatment. Int J Cardiol. 2008;124:6-21.
5. Munver R, Fromer DL, Watson RA, Sawczuk IS. Evaluation of the incidentally discovered adrenal mass. Curr Urol Rep. 2004;5:73-77.
6. Young WF Jr. The incidentally discovered adrenal mass. N Engl J Med. 2007;356:601-610.
7. Grossman A, Pacak K, Sawka A, et al. Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus? Ann N Y Acad Sci. 2006;1073:332-347.
8. Pacak K, Eisenhofer G, Ahlman H, et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab. 2007;3:92-102.
9. Yu R, Nissen NN, Chopra P, Dhall D, Phillips E, Wei M. Diagnosis and treatment of pheochromocytoma in an academic hospital from 1997 to 2007. Am J Med. 2009;122:85-95.
10. Lenders JW, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002;287:1427-1434.
11. Eisenhofer G, Goldstein DS, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab. 2003;88:2656-2666.
12. Eisenhofer G. Editorial: biochemical diagnosis of pheochromocytoma--is it time to switch to plasma-free metanephrines? J Clin Endocrinol Metab. 2003;88:550-552.
13. Kudva YC, Sawka AM, Young WF Jr. Clinical review 164: the laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab. 2003; 88:4533-4539.
14. Sawka AM, Jaeschke R, Singh RJ, Young WF Jr. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab. 2003;88:553-558.
15. Sawka AM, Prebtani AP, Thabane L, Gafni A, Levine M, Young WF Jr. A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma. BMC Endocr Disord. 2004;29:2.
16. Sawka AM, Gafni A, Thabane L, Young WF Jr. The economic implications of three biochemical screening algorithms for pheochromocytoma. J Clin Endocrinol Metab. 2004;89:2859-2866.
17. Perry CG, Sawka AM, Singh R, Thabane L, Bajnarek J, Young WF Jr. The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma. Clin Endocrinol (Oxf). 2007;66:703-708.
18. Algeciras-Schimnich A, Preissner CM, Young WF Jr, Singh RJ, Grebe SK. Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma. J Clin Endocrinol Metab. 2008;93:91-95.
19. Smythe GA, Edwards G, Graham P, Lazarus L. Biochemical diagnosis of pheochromocytoma by simultaneous measurement of urinary excretion of epinephrine and norepinephrine. Clin Chem. 1992;38:486-492.
20. Grossman E, Goldstein DS, Hoffman A, Keiser HR. Glucagon and clonidine testing in the diagnosis of pheochromocytoma. Hypertension. 1991;17:733-741.
21. Eisenhofer G, Lenders JW, Pacak K. Choice of biochemical test for diagnosis of pheochromocytoma: validation of plasma metanephrines. Curr Hypertens Rep. 2002;4:250-255.
22. Boyle JG, Davidson DF, Perry CG, Connell JM. Comparison of diagnostic accuracy of urinary free metanephrines, vanillyl mandelic acid, and catecholamines and plasma catecholamines for diagnosis of pheochromocytoma. J Clin Endocrinol Metab. 2007;92: 4602-4608.
23. Peaston RT, Weinkove C. Measurement of catecholamines and their metabolites. Ann Clin Biochem. 2004;41:17-38.